Storage and handling
Storage: Keep in a cool, dry place away from heat and direct sunlight
Storage: Keep in a cool, dry place away from heat and direct sunlight
Active ingredients: Niacinamide 0.2%, Glycerin 0.1%, Disodium EDTA 0.05%, Iron Oxides 0.005%
Purpose: Skin Protectant
Inactive Ingredients: Water, Ammonium Lauryl Sulfate, Acrylates Copolymer, Cocamidopropyl Betaine, PEG-8, Cocamide DEA, Methyl Perfluorobutyl Ether, Methyl Perfluoroisobutyl Ether, PEG-7 Glyceryl Cocoate, Triethanolamine, Lithium Magnesium, Sodium Silicate, Trehalose, Lactose, Microcrystalline Cellulose, Sucrose, Zea Mays (Corn) Starch, Silk Powder, Emu Oil
Do not use: on wounds, rashes, dermatitis or damaged skin
Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center immediately
Stop use: Please stop using this product and contact a dermatologist
1. If allergic reaction or irritation occurs
2. If direct sunlight affects the area as above
When using this product: Do not use other than directed
Warnings: For external use only. Do not use other than directed
Direction:
Step 1. Spread evenly a proper amount on the waterless face (pump 5-6 times). Surely, in order to create sufficient bubbles, use it with dry hands
Step 2. Wait for oxygen bubble what generates bubble itself
Step 3. Do not rub strongly but massage gently with fingers for better cleansing
Step 4. Wash off with lukewarm water
Storage: Keep in a cool, dry place away from heat and direct sunlight
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| GLYCERIN | ACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| GLYCERIN | ACTIVE MOIETY | PDC6A3C0OX | 1 | |
| ACRYLIC ACID/SODIUM ACRYLATE COPOLYMER (1:1; 600 MPA.S AT 0.2%) | INACTIVE INGREDIENT | M4PPW69Y4H | 1 | |
| AMMONIUM LAURYL SULFATE | INACTIVE INGREDIENT | Q7AO2R1M0B | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | 1 | |
| COCAMIDOPROPYL BETAINE | INACTIVE INGREDIENT | 5OCF3O11KX | 1 | |
| EMU OIL | INACTIVE INGREDIENT | 344821WD61 | 1 | |
| LACTOSE | INACTIVE INGREDIENT | J2B2A4N98G | 1 | |
| METHYL PERFLUOROBUTYL ETHER | INACTIVE INGREDIENT | H637A50B7U | 1 | |
| METHYL PERFLUOROISOBUTYL ETHER | INACTIVE INGREDIENT | HI89P35AAX | 1 | |
| PEG-7 GLYCERYL COCOATE | INACTIVE INGREDIENT | VNX7251543 | 1 | |
| SODIUM SILICATE | INACTIVE INGREDIENT | IJF18F77L3 | 1 | |
| SUCROSE | INACTIVE INGREDIENT | C151H8M554 | 1 | |
| TREHALOSE | INACTIVE INGREDIENT | B8WCK70T7I | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 59370-100 | 59370-100-01 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| LACTOSE | LACTOSE | J2B2A4N98G | SOLUTION / ORAL | 1682 mg/15ml | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 1576 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | PELLET / ORAL | 1140 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | SUPPOSITORY / RECTAL | NA | ||
| SUCROSE | SUCROSE | C151H8M554 | SYRUP / ORAL | 46400 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TROCHE / BUCCAL | NA | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, DELAYED RELEASE / ORAL | 295.33 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | WAFER / ORAL | 155.2 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | INJECTION, SUSPENSION, EXTENDED RELEASE / SUBCUTANEOUS | 1 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FOR SUSPENSION / ORAL | 20100 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | SUPPOSITORY / VAGINAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | GRANULE, FOR SUSPENSION / ORAL | 512.5 mg/5ml | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | POWDER, FOR SUSPENSION / ORAL | 4441 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CONCENTRATE / ORAL | NA | ||
| LACTOSE | LACTOSE | J2B2A4N98G | POWDER / RESPIRATORY (INHALATION) | 90 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET / BUCCAL | 296.7 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | POWDER, FOR SUSPENSION / ORAL | 40017 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | DROPS / ORAL | NA | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, DELAYED RELEASE / ORAL | 2210 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | OINTMENT / TOPICAL | NA | ||
| AMMONIUM LAURYL SULFATE | AMMONIUM LAURYL SULFATE | Q7AO2R1M0B | SHAMPOO, SUSPENSION / TOPICAL | 30 %w/w | ||
| SUCROSE | SUCROSE | C151H8M554 | LOZENGE / TRANSMUCOSAL | 1255 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | INJECTABLE, LIPOSOMAL / INTRAVENOUS | 7560 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, COATED / ORAL | 920 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | INJECTION / INTRAVENOUS | 1950 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET / SUBLINGUAL | 352 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | POWDER / ORAL | 27768 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE / ORAL | 530 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, EFFERVESCENT / ORAL | 96.5 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / BUCCAL | 18 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVITARY | 193.8 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS | 133 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | GRANULE, FOR SUSPENSION / ORAL | 278 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR | 133 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | CAPSULE / ORAL | 3568 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | GRANULE, FOR SUSPENSION / ORAL | 31885 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | CAPSULE, COATED PELLETS / ORAL | 135.2 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS | 308 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, DELAYED RELEASE PARTICLES / ORAL | 580 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 144 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET / ORAL | 4249 mg | ||
| AMMONIUM LAURYL SULFATE | AMMONIUM LAURYL SULFATE | Q7AO2R1M0B | AEROSOL / TOPICAL | NA | ||
| SUCROSE | SUCROSE | C151H8M554 | SUSPENSION / ORAL | 48209 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | CAPSULE, COATED, EXTENDED RELEASE / ORAL | 86 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | LIQUID / ORAL | 37500 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | INJECTION, SOLUTION / INTRAVENOUS | NA | ||
| SUCROSE | SUCROSE | C151H8M554 | LOZENGE / BUCCAL | NA | ||
| SUCROSE | SUCROSE | C151H8M554 | SUSPENSION, EXTENDED RELEASE / ORAL | 5400 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET, FILM COATED / ORAL | 992 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | TABLET, CHEWABLE / ORAL | 1412 mg | ||
| SUCROSE | SUCROSE | C151H8M554 | GRANULE, FOR SUSPENSION, EXTENDED RELEASE / ORAL | 18790 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | TABLET / SUBLINGUAL | 43.2 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | POWDER, FOR SOLUTION / ORAL | 690 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | IMPLANT / INTRAVITREAL | 1.66 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | POWDER, FOR SOLUTION / ORAL | NA | ||
| SUCROSE | SUCROSE | C151H8M554 | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 2000 mg | ||
| CELLULOSE, MICROCRYSTALLINE | MICROCRYSTALLINE CELLULOSE | OP1R32D61U | CAPSULE, EXTENDED RELEASE / ORAL | 1246 mg | ||
| LACTOSE | LACTOSE | J2B2A4N98G | INJECTION / INTRAVENOUS | 203.5 mg | ||
| SODIUM SILICATE | SODIUM SILICATE | IJF18F77L3 | SOAP / TOPICAL | 0.36 %w/w | ||
| SUCROSE | SUCROSE | C151H8M554 | TABLET, FILM COATED / ORAL | 145 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Wart Remover | GLYCERIN | Shantou Ouhoe Technology Co., Ltd. | 5af3afe1-dad5-91b7-e063-6294a90ab95e | 2026-09-08 | Warnings | GLYCERIN |
| Clear Eyes Nighttime | GLYCERIN | Prestige Brands Holdings, Inc. | af75e2f7-81dd-43e0-a390-b52bbfbebf62 | 2026-09-08 | Warnings | GLYCERIN |
| Nail Treatment Liquid | GLYCERIN | Shantou Ximonth Biotechnology Co., Ltd. | 5a7cd607-a50e-17d0-e063-6294a90acdb2 | 2026-09-02 | Warnings | GLYCERIN |
| Hair Regrowth Foam | GLYCERIN | Shantou Ouhoe Technology Co., Ltd. | 59ef5953-e96f-5707-e063-6294a90a3094 | 2026-08-26 | Warnings | GLYCERIN |
| Growth Treatment | GLYCERIN | Shantou Ouhoe Technology Co., Ltd. | 59fe12eb-574f-a199-e063-6394a90abd06 | 2026-08-26 | Warnings | GLYCERIN |
| SWRDHJ Hair Growth Serum | GLYCERIN | Guangzhou Houkea Biotechnology Co., Ltd. | 59da3063-66bd-31d2-e063-6294a90abab5 | 2026-08-25 | Warnings | GLYCERIN |
| Izzch1219 Hair Growth Form | GLYCERIN | Guangzhou Houkea Biotechnology Co., Ltd. | 59da92a8-17a4-b894-e063-6294a90a37ed | 2026-08-25 | Warnings | GLYCERIN |
| YIUI Hair Regrowth Foam | GLYCERIN | Guangzhou Houkea Biotechnology Co., Ltd. | 59d7399e-aeb1-824b-e063-6394a90aebe8 | 2026-08-24 | Warnings | GLYCERIN |
| Nail Renewal Liquid | GLYCERIN | Shantou Eelhoe Daily Chemical Technology Co., Ltd. | 581f7192-fc17-a706-e063-6394a90a3ffa | 2026-08-11 | Warnings | GLYCERIN |
| Intertrigo Relief Cream | GLYCERIN | Shantou South Moon Biotechnology Co., Ltd. | 587220c9-0ae9-3438-e063-6394a90a0a86 | 2026-08-07 | Warnings | GLYCERIN |
| Nail Treatment Repairing Liquid | GLYCERIN | Shantou Ximonth Biotechnology Co., Ltd. | 57b8b3e5-88be-3a91-e063-6294a90a05be | 2026-08-03 | Warnings | GLYCERIN |
| HOUKEA Bee Venom Skin Restoration Cream | GLYCERIN | Guangzhou Houkea Biotechnology Co., Ltd. | 57a8a8e9-7f18-ad01-e063-6394a90a1eac | 2026-07-29 | Warnings | GLYCERIN |
| Topwin Speedy Enema | GLYCERIN | Health Chemical Pharmaceutical Co., Ltd | 3ba8c3d2-1780-42e1-bec5-8f98771d475e | 2026-07-27 | Warnings | GLYCERIN |
| SOHEJU Nail Repairs Patches | GLYCERIN | Shantou Ximonth Biotechnology Co., Ltd. | 560089ff-3361-90b7-e063-6294a90ada42 | 2026-07-09 | Warnings | GLYCERIN |
| Bee Venom Psoriasis Wart Caring Cream | GLYCERIN | Shantou Ximonth Biotechnology Co., Ltd. | 563a423c-e9dd-1cab-e063-6294a90a8c6a | 2026-07-09 | Warnings | GLYCERIN |
| Glycerin | GLYCERIN | Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd | 552d9018-cc7d-7e1a-e063-6294a90a3322 | 2026-06-26 | Warnings | GLYCERIN |
| Glycerin | GLYCERIN | Beijing Jingfeng Pharmaceutical (Shandong) Co., Ltd | 552e16b9-f46a-7838-e063-6394a90ab8aa | 2026-06-26 | Warnings | GLYCERIN |
| EELHOE Sleep Aid Patch | GLYCERIN | Shantou Eelhoe Daily Chemical Technology Co., Ltd. | 550b0494-ca6d-c897-e063-6394a90a8751 | 2026-06-24 | Warnings | GLYCERIN |
| Hair Regrowth Liquid | GLYCERIN | Shantou Woodsleep Biotechnology Co., Ltd. | 54e662e7-9c63-ad6b-e063-6294a90a1b8d | 2026-06-23 | Warnings | GLYCERIN |
| MINICA-S | GLYCERIN | Sato Pharmaceutical Co., Ltd. | 687902eb-e702-4e87-a0ce-9add05e3cbc1 | 2026-06-16 | Warnings | GLYCERIN |
Adverse event summaries are temporarily unavailable. Other product information remains available.